GEMCITABINE

Manufacturer:

Fresenius Kabi

Name:

GEMCITABINE

HCPCS Code Descriptor:

Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg

Category:

J Code

HCPCS:

J9201

NDC(s):

71288-0117-06, 71288-0117-28, 71288-0117-54, 71288-0114-50, 71288-0113-10, 70860-0205-50, 68001-0359-37, 68001-0348-36, 68001-0342-34, 68001-0282-26, 67457-0618-10, 67457-0617-30, 67457-0616-10, 67457-0462-01, 67457-0464-20, 63323-0125-53, 63323-0125-94, 63323-0126-00, 63323-0126-03, 63323-0102-13, 63323-0102-94, 60505-6113-06, 60505-6114-00, 60505-6115-02, 55111-0687-25, 55111-0686-07, 47335-0154-40, 47335-0153-40, 25021-0239-52, 25021-0239-26, 25021-0239-05, 25021-0235-50, 25021-0235-51, 25021-0234-10, 23155-0529-31, 23155-0528-31, 23155-0484-31, 23155-0483-31, 23155-0213-31, 23155-0214-31, 16729-0118-38, 16729-0092-03, 16714-0930-01, 16714-0909-01, 00409-0187-01, 00409-0186-01, 00409-0185-01, 00409-0183-25, 00409-0183-01, 00409-0182-25, 00409-0182-01, 00409-0181-25, 00409-0181-01, 00143-9394-01

Primary Type:

Oncology

Generic Status:

Multi-Source

Route of Administration:

Intravenous

About:

GEMCITABINE is an Oncology drug manufactured by Fresenius Kabi and administered via the Intravenous route of administration. The J Code: J9201 is aligned to the drug GEMCITABINE.